We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
The current HQL market cap is 339.48M. The company's latest EPS is USD 3.3215 and P/E is 4.01.
| Quarter End | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | |||||
| Operating Income | |||||
| Net Income |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.39M | 2.29M | 3.02M | 3.5M | 3.98M |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | 123.05M | 64.53M | -104.6M | 22.35M | 85.3M |
| Quarter End | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | |||||
| Total Liabilities | |||||
| Total Equity |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 484.17M | 534.19M | 414.73M | 402.6M | 460.58M |
| Total Liabilities | 596k | 10.75M | 16.82M | 666k | 889k |
| Total Equity | 483.57M | 523.44M | 397.9M | 401.93M | 459.69M |
| Market Cap | 339.48M |
| Price to Earnings Ratio | 4.01 |
| Price to Sales Ratio | 85.87 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0.74 |
| Dividend Yield | 14.83% |
| Shares Outstanding | 25.68M |
| Average Volume (1 week) | 99.21k |
| Average Volume (1 Month) | 97.34k |
| 52 Week Change | -1.78% |
| 52 Week High | 15.8999 |
| 52 Week Low | 12.76 |
| Spread (Intraday) | 0.07 (0.52%) |
| Company Name | abrdn Life Sciences Investors |
| Address |
100 federal street boston, massachusetts 02110 |
| Website | https://www.teklacap.com/hql.html |
| Industry | unit inv tr, closed-end mgmt (6726) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
